Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study.

scientific article published in December 2012

Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/SLA.0B013E318254F281
P698PubMed publication ID22580940

P50authorPeter H. CashinQ50945433
Peter NygrenQ66206118
P2093author name stringHaile Mahteme
Wilhelm Graf
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
peritoneal carcinomatosisQ2071182
P304page(s)1078-1083
P577publication date2012-12-01
P1433published inAnnals of SurgeryQ4767866
P1476titlePatient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study.
P478volume256

Reverse relations

cites work (P2860)
Q87821321A new technique to improve surgery for peritoneal colorectal metastases?
Q90102491ASO Author Reflections: Can Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy be Improved?
Q36792339Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy
Q64092130Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research
Q42615377Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Q48645092Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI).
Q36762307Computerized System for Staging Peritoneal Surface Malignancies
Q44408342Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study.
Q47998828External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer
Q40312433Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Q26849259Looking up: Recent advances in understanding and treating peritoneal carcinomatosis
Q90533514Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept
Q90392289Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
Q36748744Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: analysis from a single oncological center
Q46596474The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer
Q50578314Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Search more.